Cloud-based SaaS Platform for Healthcare Providers
Healthcare SaaS Platform in the Northeast US
On NextCompany since September 30, 2026 (15 days)
Location undisclosed
Business overview
This Northeast US healthcare SaaS company provides seven platforms for scheduling, billing, reporting, personnel, and compliance. It served approximately 1,000 customer accounts in 2025, primarily in the US, alongside international customers. Monthly recurring revenue accounted for 100% of revenue in 2025. The business reports $2,376,394 in gross revenue and $935,211 in EBITDA.
A small full-time team uses automated onboarding and support. The company leases two sales offices, and its primary office may transfer with a sale. One equal shareholder expects to exit; the other is willing to continue after closing.
Who is a good fit for this business
- Healthcare software acquirers seeking a platform with seven tools for provider operations.
- Buyers seeking SaaS revenue that came entirely from monthly recurring subscriptions in 2025.
- Strategic acquirers pursuing international expansion from a primarily US customer base.
Details
- Reason for selling
- One of two equal shareholders expects to exit; the remaining shareholder is willing to continue post-closing to support operational continuity and growth.
- Real estate
- Leased
Frequently Asked Questions
The company provides seven specialized platforms covering scheduling, billing, reporting, personnel, and compliance. Its multi-tenant architecture supports those services.
The business reports $2,376,394 in gross revenue and $935,211 in EBITDA. Monthly recurring revenue accounted for 100% of revenue in 2025, and revenue grew at an 8.9% CAGR during 2022-2025.
The company served approximately 1,000 customer accounts in 2025. Most customers were in the US, and the customer base also included international accounts.
A small full-time team uses automated onboarding and support. Sales and support staff work mostly remotely, and the company leases two sales offices. Its primary office may transfer with a sale.
One of two equal shareholders expects to exit. The remaining shareholder is willing to continue after closing to support operations and growth.